DLA Piper advised Kunlun Energy on the sale of its 60% equity interest in PetroChina Beijing Gas Pipeline and a 75% equity interest in PetroChina Dalian LNG to the China Oil & Gas Pipeline Network Corporation (PipeChina) for a total base consideration of RMB40.89 billion (US$6.24 billion).
The sale by Kunlun Energy is aimed at optimising its business structure to allow it to actively expand its remaining relevant businesses and to progress its transformation from a natural gas distributor to an integrated green energy supplier.
The controlling shareholder of Kunlun Energy is state-owned company PetroChina, which is listed in Hong Kong, Shanghai, and New York.
Zhong Lun Law Firm advised Yatsen, the US-listed Chinese cosmetics maker, in its acquisition of French luxury skincare brand Eve Lom from Manzanita Capital.
Manzanita will retain a minority stake in the business and serve as a strategic partner.
Baker McKenzie is advising C-Lab International, a wholly owned subsidiary of Sino Biopharmaceutical, on its acquisition of Belgian drug maker Softhale for US$110 million.
Sino Biopharmaceutical is a research and development-driven pharmaceutical company in China. Softhale is a privately owned company focused on the development of products for the treatment of respiratory diseases.